You will be shown a claim about public health, and the abstract of a biomedical research paper. Each sentence from the abstract will be on a separate line. Your task is to return a JSON object with two fields:

- "verdict": The fact-checking verdict. If the information in the abstract supports the claim, write "SUPPORT". If the abstract contradicts the claim, write "CONTRADICT". If the abstract does not provide enough information to arrive at a verdict, write "NEI" (for "not enough information").
- "evidence": An array of sentences providing evidence for the verdict. Please copy all relevant sentences verbatim from the abstract. If the verdict was "NEI", then return an empty array.

For instance, if the model were given the claim "wearing masks can prevent the spread of COVID", the output might be
{
  "verdict": "SUPPORT",
  "evidence": ["Our findings indicate that mass mask-wearing reduces the transmission rate for COVID-19."]
}

Claim: People may take ibuprofen for body aches, headaches, or chronic health conditions, such as arthritis or lupus.

Abstract:
Coronavirus infection 2019 is considered a modern challenge to the world community.
In the absence of vaccines and antivirals, effective and safe medicines are an urgent request from the healthcare system.
We have evaluated the medical technologies for COVID-19 which are being examined.
The search was conducted on the СlinicalTrials.gov at the beginning of April 2020.
As a result it was shown that the growth of new clinical trials in the world devoted to COVID-19 is growing by 65% per week.
More often, interventional clinical trials of the II and III phases are carried out.
Most studies are planned or conducted in Western Europe (n = 92), China (n = 79), and the United States (n = 51).
Surrogate points are usually evaluated, such as: clinical recovery, symptom-based disease relief (fever, cough, diarrhea, myalgia, shortness of breath), lack of progression of shortness of breath, rate of artificial ventilation, rate of admission to the intensive care unit, etc.
It is antimalarial drugs that are mainly studied.
Currently, it is not possible to discuss the efficacy and safety of a drug in the treatment of COVID-19, as most studies have just begun.
The therapeutic regimens proposed now in clinical recommendations have no evidence base, and the studies indicated in them are at best considered hypothesizing.
{"verdict": "NEI", "evidence": []}